Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 36.8K | $96.4K | $2.62 | May 13, 2024 | Direct |
AMARIN CORP PLC\UK | Director | Stock Option (right to buy) | 180K | Apr 18, 2024 | Direct | ||
AMARIN CORP PLC\UK | Director | Restricted Stock Unit | 50.3K | Apr 18, 2024 | Direct | ||
LEXICON PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 44.9K | May 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXRX | LEXICON PHARMACEUTICALS, INC. | May 13, 2024 | 2 | $0 | 4 | May 13, 2024 | Director |
AMRN | AMARIN CORP PLC\UK | Apr 18, 2024 | 2 | $0 | 4 | Apr 19, 2024 | Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | Jul 27, 2023 | 1 | $0 | 4 | Jul 31, 2023 | Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | Jul 27, 2023 | 0 | $0 | 3 | Jul 31, 2023 | Director |
AMRN | AMARIN CORP PLC\UK | Jul 21, 2023 | 4 | $0 | 4 | Jul 21, 2023 | Director |
AMRN | AMARIN CORP PLC\UK | Feb 28, 2023 | 0 | $0 | 3 | Mar 10, 2023 | Director |